OBJECTIVE: To determine the degree to which documented knee osteoarthritis (OA) care in a teaching rheumatology clinic corresponds to evidence-based treatment guidelines. METHODS: The charts of 105 randomly selected patients meeting criteria for knee OA were reviewed. The patients received care from 3 rheumatologists working in a major Canadian teaching center between 2002 and 2005. The chart abstraction tool was based on European League Against Rheumatism, American College of Rheumatology, and The Arthritis Society guidelines for OA treatment. Descriptive statistics were used for patient demographics and the proportion of patients receiving recommended care. RESULTS: The most frequently recommended nonpharmacologic treatments were any kind of exercise (58.1%), weight loss in those overweight (50.0%), physiotherapy (42.9%), and strengthening exercise (40.0%). Other nonpharmacologic treatments were documented in less than 30% of patient charts. The most frequently prescribed pharmacologic treatments were acetaminophen (68.6%), intraarticular (IA) corticosteroids (65.7%), nonsteroidal antiinflammatory drugs/cyclooxygenase-2-selective inhibitors (COXIB; 50.5%), and IA hyaluronans (43.8%). Topical pharmaceuticals, glucosamine/chondroitin, and opioid analgesics were recommended to less than 20% of the patients. Exploratory analyses suggested the following factors may be associated with increased documentation of recommended care: female sex, younger age, overweight, more clinic visits, decreased symptom length, and the individual rheumatologist. CONCLUSION: Nonpharmacologic knee OA treatments currently recommended by practice guidelines were seldom documented in patients' charts in this Canadian rheumatology teaching center. These findings are similar to studies conducted before the practice guidelines became available and to results reported from general practices. This suggests the need for reminder systems or other strategies to promote physician adherence to current guidelines.
OBJECTIVE: To determine the degree to which documented knee osteoarthritis (OA) care in a teaching rheumatology clinic corresponds to evidence-based treatment guidelines. METHODS: The charts of 105 randomly selected patients meeting criteria for knee OA were reviewed. The patients received care from 3 rheumatologists working in a major Canadian teaching center between 2002 and 2005. The chart abstraction tool was based on European League Against Rheumatism, American College of Rheumatology, and The Arthritis Society guidelines for OA treatment. Descriptive statistics were used for patient demographics and the proportion of patients receiving recommended care. RESULTS: The most frequently recommended nonpharmacologic treatments were any kind of exercise (58.1%), weight loss in those overweight (50.0%), physiotherapy (42.9%), and strengthening exercise (40.0%). Other nonpharmacologic treatments were documented in less than 30% of patient charts. The most frequently prescribed pharmacologic treatments were acetaminophen (68.6%), intraarticular (IA) corticosteroids (65.7%), nonsteroidal antiinflammatory drugs/cyclooxygenase-2-selective inhibitors (COXIB; 50.5%), and IAhyaluronans (43.8%). Topical pharmaceuticals, glucosamine/chondroitin, and opioid analgesics were recommended to less than 20% of the patients. Exploratory analyses suggested the following factors may be associated with increased documentation of recommended care: female sex, younger age, overweight, more clinic visits, decreased symptom length, and the individual rheumatologist. CONCLUSION: Nonpharmacologic knee OA treatments currently recommended by practice guidelines were seldom documented in patients' charts in this Canadian rheumatology teaching center. These findings are similar to studies conducted before the practice guidelines became available and to results reported from general practices. This suggests the need for reminder systems or other strategies to promote physician adherence to current guidelines.
Authors: Agnes J Smink; Cornelia H M van den Ende; Thea P M Vliet Vlieland; Bart A Swierstra; Joke H Kortland; Johannes W J Bijlsma; Theo B Voorn; Henk J Schers; Sita M A Bierma-Zeinstra; Joost Dekker Journal: Clin Rheumatol Date: 2011-09-02 Impact factor: 2.980
Authors: Lauren M Abbate; Amy S Jeffreys; Cynthia J Coffman; Todd A Schwartz; Liubov Arbeeva; Leigh F Callahan; Nicole A Negbenebor; Wendy M Kohrt; Robert S Schwartz; Ernest Vina; Kelli D Allen Journal: Arthritis Care Res (Hoboken) Date: 2018-07-05 Impact factor: 4.794
Authors: Miriam G Cisternas; Edward Yelin; Jeffrey N Katz; Daniel H Solomon; Elizabeth A Wright; Elena Losina Journal: Arthritis Rheum Date: 2009-12-15